- Home
- CRDO vs HALO Comparison
CRDO vs HALO Comparison
Compare CRDO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDO | HALO |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 7.4B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDO | HALO |
|---|---|---|
| Price | $145.00 | $69.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $179.91 | $73.33 |
| AVG Volume (30 Days) | ★ 6.3M | 2.2M |
| Earning Date | 12-01-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | 1.11 | ★ 4.74 |
| Revenue | $796,128,000.00 | ★ $1,242,852,000.00 |
| Revenue This Year | $177.26 | $34.83 |
| Revenue Next Year | $37.90 | $24.84 |
| P/E Ratio | $130.17 | ★ $14.56 |
| Revenue Growth | ★ 224.17 | 31.19 |
| 52 Week Low | $29.09 | $47.50 |
| 52 Week High | $213.80 | $79.50 |
Technical Indicators
Market Signals| Indicator | CRDO | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 43.97 | 59.05 |
| Support Level | $143.12 | $67.95 |
| Resistance Level | $152.30 | $69.48 |
| Average True Range (ATR) | 8.50 | 1.50 |
| MACD | -1.05 | 0.66 |
| Stochastic Oscillator | 26.29 | 92.85 |
Price Performance
Historical ComparisonAbout CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.